Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants
{{output}}
Background and objectives: Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract disease (LRTD) in infants and young children. In 2023, the Advisory Committee on Immunization Practices recommended ... ...
